🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Terrific talk by ⁦Khue Ton⁩ on #CSWG #SCAI stages progression in cardiogenic shock #ESCCongress. Simultaneous pub in ⁦JACC Journals⁩ jacc.org/doi/epdf/10.10… ⁦Navin Kapur⁩ ⁦Manreet Kanwar⁩ ⁦Jaime Hernandez-Montfort⁩ ⁦Dan Burkhoff MD PhD⁩ ⁦Deutsche Gesellschaft für Kardiologie⁩

Nothing to ‘SCOFF’ at! New research out of #ESCCongress suggests fasting prior to cath lab procedures requiring conscious sedation may not be needed. Read more: bit.ly/3XgwbOy

Love this contribution from the The Cardiogenic Shock Working Group, spearheaded by the person who introduced me to #CSWG - Khue Ton !! Congratulations to you and to all the CSWG PIs. Serial shock assessment is SO important and it’s great to have good quality data to support that. Navin Kapur

#ESCCongress 2024, London, UK Can we identify who are the advanced HF patients that can recover their hearts ? Can we use a practical personalized tool to guide our recommendations for our patients’ therapeutic options: LVAD as bridge to recovery Vs. direct heart Tx or other ?

On behalf of our multicenter team we presented at #ESCCongress 2024: Multicenter Model to Determine the Individualized Probability of Myocardial Recovery: The RecoverHeart Calculator THANK YOU to the 7 participating sites and co-investigators (see picture)

Happening now in Belgrade: dive into the latest breakthroughs in #hypertension drug therapies! 💊 Led by the expert chairs BiykemBozkurt and #AnthonyRodgers—! #ESCCongress

📌 FINEARTS-HF 👉 In 👫 w/ HFmrEF or HFpEF, finerenone signif ⬇️ the composite of worsening HF & CV death #HeartFailure #CardioTwitter Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Dr Anastasia Mihailidou FAHA FCSANZ FESC Jag Singh Giuseppe Galati Diego Segura-Rodríguez Alfonso Valle Dr.Rajiv Sankaranarayanan Robert Mentz, MD Quentin Youmans, MD, MSc, FACC Anju Bhardwaj MD FACC

We describe our institutional experience for 4 allosensitized individuals for HALT-D. All 4 have done clinically well, with only 1 recipient developing low level DSA’s to date. The ISHLT Michelle Kittleson MD PhD Nasrien E. Ibrahim MD, MPH Khadijah Breathett, MD, MS, FACC, FAHA, FHFSA UWashington Heart Institute pubmed.ncbi.nlm.nih.gov/39222736/

New JACC Journals #JACCHF 🫀❤️‍🩹 ‼️Rapid uptitration of #GDMT ▪️⬇️ #HF-related morbidity & mortality  🌟Regardless of underlying HF risk profile DOI: 10.1016/j.jchf.2024.04.017

ACC Practice Made Perfect: Building Your Brand - American College of Cardiology #ACCWIC acc.org/Latest-in-Card…

New in #JACCHF: REVIVED-BCIS2 showed PCI in addition to #GDMT in #ICM did not improve health status beyond 6 months compared with #GDMT alone. PCI should not be recommended for all ICM. jacc.org/doi/10.1016/j.… Editorial: jacc.org/doi/10.1016/j.…

New in #JACCHF: 🔥 Obesity & Weight Loss Strategies for Patients with Heart Failure Nice review of this important target in the management of #HF JACC Journals JACC HF: jacc.org/doi/10.1016/j.…

TCACC Member Spotlight: Meet your WIC Section co-chairs Bindu Chebrolu and Anjlee Mehta. 🫀🩺Get involved with the Women in Cardiology section by clicking here: bit.ly/3Tc1s3J #HeartDoc #TexasMD #TXMD

In the #DOAC #LVAD (phase II trial): #Apixaban + ASA 81 mg (vs Warfarin + ASA 81 mg) was NOT associated with excess mortality or major hemocompatibility events in patients with HeartMate 3 For more details: shorturl.at/hD7AG